We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SBID:LSINState Bank of India Sponsored GDR RegS Analysis

Data as of 2026-03-14 - not real-time

$114.60

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

State Bank of India is trading at $114.6, sitting just above the identified support of $113.4 but below both the 20‑day ($128.3) and 50‑day ($121.6) simple moving averages, indicating a short‑term pull‑back within a longer‑term bullish framework (price above the 200‑day SMA of $104.7). The RSI of 31.8 points to oversold conditions, while a bearish MACD histogram and a negative MACD line versus a positive signal line suggest lingering downside momentum. Volume is on the rise, reinforcing the bullish trend direction flagged by the model, and the market’s “Greed” sentiment (Fear & Greed Index 72.9) adds a layer of optimism despite the technical mixed signals.
Valuation and fundamentals paint a more nuanced picture: the trailing P/E of 12.7 is well below the industry average of 16.4, and the price‑to‑book ratio of 0.03 signals deep discounting relative to book value. A solid dividend yield of 2.05% with a modest 15% payout ratio underlines dividend sustainability. However, forward‑looking metrics are concerning—forward P/E jumps to nearly 49 and forward EPS is projected to tumble, reflected in analyst target prices around $104, implying expected earnings pressure. Overall, the stock sits at the intersection of attractive valuation and dividend fundamentals but faces short‑term technical headwinds and earnings uncertainty.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Oversold RSI suggesting near‑term upside
  • Support level just below current price
  • Increasing volume supporting a potential bounce

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Forward earnings compression reflected in high forward P/E
  • Analyst target price below current market level
  • Stable dividend yield providing income while earnings normalize

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong ROE (~19%) and solid profit margins
  • Deep discount to book value and low trailing P/E versus peers
  • Sustained dividend payout with low payout ratio

Key Metrics & Analysis

Financial Health

Revenue Growth48.80%
Profit Margin24.79%
P/E Ratio12.7
ROE19.16%
ROA1.21%
P/B Ratio0.0
Industry P/E16.4

Technical Analysis

TrendBullish
RSI31.8
Support$113.40
Resistance$138.00
MA 20$128.31
MA 50$121.62
MA 200$104.75
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target Price$104.30
Upside/Downside-8.99%
GradeUndervalued
TypeValue
Dividend Yield2.05%

Risk Assessment

Beta0.14
Volatility41.10%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.